Newest
BETR ▼ sold $13K · Tuffin Paula filed 2d agoBETR ▼ sold $14K · Nicholas J. Calamari filed 2d agoFBK ▲ bought $716K · INGRAM ORRIN H II filed 2d agoFBK ▲ bought $821K · INGRAM ORRIN H II filed 2d agoBEN ▼ sold $5.0M · FRANKLIN TEMPLETON INC filed 2d agoNAD ▼ sold $338K · Robert Young L filed 3d agoWSBC ▼ sold $15K · Rep. Michael A. Rulli filed 4d agoGOOG ▼ sold $100K · Rep. Michael A. Rulli filed 4d agoWMT ▼ sold $100K · Rep. Jonathan L. Jackson filed 4d agoVSAT ▼ sold $100K · Rep. Jonathan L. Jackson filed 4d agoTYG ▼ sold $15K · Rep. Jonathan L. Jackson filed 4d agoGH ▲ bought $50K · Rep. Jonathan L. Jackson filed 4d agoEL ▲ bought $100K · Rep. Jonathan L. Jackson filed 4d agoDDOG ▲ bought $100K · Rep. Jonathan L. Jackson filed 4d agoCPRT ▼ sold $553K · Morefield Diane M filed 4d agoPTON ▼ sold $154K · Kirol Charles Peter filed 4d agoEME ▲ bought $1K · MCEVOY M KEVIN filed 4d agoEME ▲ bought $826 · MCEVOY M KEVIN filed 4d ago

Stock / equity

RARE Ultragenyx Pharmaceutical Inc.

Company
Ultragenyx Pharmaceutical Inc.
Security
Equity
Size, estimated from filings
Small cap ($300M – $2B)
Insiders on record
15
Members of Congress
1
Latest trade on record
October 15, 2026

RARE (Ultragenyx Pharmaceutical Inc.) has 67 disclosed insider transactions from 15 insiders in the last 12 months (0 open-market buys, 30 sales, about $3.8M at reported prices) and 3 congressional trades from 1 member of Congress. The most recent disclosure was filed October 19, 2026.

Last updated October 19, 2026 · Sources: SEC EDGAR Form 4; House Clerk and Senate eFD PTRs

Insider txns (12m)
67
Open-market buys / sales
0 / 30
Congress trades (12m)
3
Distinct filers (12m)
16

Share price

Price and chart by TradingView for Ultragenyx Pharmaceutical Inc.. US share prices here are delayed, not real-time. The trade records on this page come from government filings, not from this chart.

RARE in charts

Who is trading this stock

Which people account for the buying and selling over the last 12 months?

BoughtSold

8 people account for the disclosed buying and selling in RARE over the last 12 months; the most active is KAKKIS EMIL D with $1.2M.

Embed this chart
<iframe src="https://spotthemoney.com/embed/stocks/rare/" width="640" height="360" loading="lazy" style="border:0;max-width:100%" title="Who is trading RARE — Spot the Money"></iframe>
<p>Source: <a href="https://spotthemoney.com/stocks/rare/">Spot the Money</a></p>

Prices insiders traded at

What price did insiders buy and sell at? Each marker is one open-market trade at the share price reported on its Form 4.

▲ Bought▼ SoldAverage reported price that day
$10$20$30$40Oct 2025Oct 2026
$10$20$30$40Oct 2025Oct 2026

Insiders reported 29 open-market trades in RARE since Oct 13, 2025, at prices from $13.57 to $36.38; the most recent was a sale at $15.27 on Oct 15, 2026. These are the prices on the filings, not adjusted for stock splits, and not a market price series.

Insider holdings over time

Is an insider building or unwinding a position? Shares held directly after each filing.

Horn HowardHuizenga Theodore Alan
058K115K89K68K2025-10-142026-10-19

Horn Howard reported 89,229 shares held after the latest filing, against 98,227 at the first on record.

Lobbying spend by quarter

How much has Ultragenyx Pharmaceutical Inc. reported spending on federal lobbying?

Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26
Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26

Ultragenyx Pharmaceutical Inc. reported $2.0M in lobbying over the last eight quarters, from filings matched by exact company name.

Insiders trading RARE

Everyone who filed a Form 4 for this ticker, by number of rows on record. "Bought" and "sold" count open-market purchases (code P) and sales only; awards, option exercises and shares withheld for tax are in the row count but not in those two columns.

InsiderRoleRowsBoughtSoldValue boughtValue soldLatest
Horn HowardChief Financial Officer16013—$1.4MOctober 15, 2026
Parschauer Karah HerdmanEVP and Chief Legal Officer805—$488KAugust 3, 2026
Huizenga Theodore AlanSVP, Chief Accounting Officer705—$63KSeptember 15, 2026
Crombez EricEVP and Chief Medical Officer502—$169KMay 5, 2026
Harris ErikEVP & Chief Commercial Officer401—$240KApril 16, 2026
Huang Dennis KarlSee Remarks401—$23KApril 16, 2026
KAKKIS EMIL DPresident & CEO401—$1.2MApril 16, 2026
Pinion John RichardSee Remarks401—$229KApril 16, 2026
Sanders Corazon (Corsee) D.Director301—$50KJune 15, 2026
SULIMAN SHEHNAAZDirector301—$144KMay 18, 2026
Dunsire DeborahDirector200——May 14, 2026
Fust Matthew KDirector200——May 14, 2026
NARACHI MICHAELDirector200——May 14, 2026
Ray AmritDirector200——May 14, 2026
WELCH DANIEL GDirector200——May 14, 2026
What kind of transactions these are 3 Form 4 codes
CodeMeaningRowsSharesValue at reported prices
AGrant or award371,076,773—
SOpen-market sale29172,463$4.1M
FShares withheld for tax21,147$27K

What each code means: Form 4 transaction codes.

Members of Congress trading RARE

Members whose periodic transaction reports name this ticker. Amounts are the sums of the ranges as filed.

MemberSeatTradesBoughtSoldRange as filedLatest
Gilbert Ray Cisneros, Jr.Representative (CA, District 31), Democrat330$3,003–$45KSeptember 29, 2026

Download CSV71 rows · 26 KB · insider and congressional rows for this ticker · all downloads

Insider transactions

FilerSideTrade dateDisclosedLagSharesPriceValueFlagsSourceShare
Horn HowardSell SOctober 15, 2026October 19, 20264d7,066$15$108KForm 4 ↗
Huizenga Theodore AlanSell SSeptember 15, 2026September 15, 20260d1,283$14$17K10b5-1 planForm 4 ↗
Huizenga Theodore AlanSell SSeptember 3, 2026September 8, 20265d161$14$2,252lateForm 4 ↗
Parschauer Karah HerdmanSell SAugust 3, 2026August 4, 20261d1,900$25$47K10b5-1 planForm 4 ↗
Horn HowardSell SAugust 3, 2026August 4, 20261d4,696$25$117K10b5-1 planForm 4 ↗
Horn HowardSell SJuly 1, 2026July 6, 20265d4,698$33$156Klate10b5-1 planForm 4 ↗
Sanders Corazon (Corsee) D.Sell SJune 15, 2026June 15, 20260d2,000$25$50KForm 4 ↗
Parschauer Karah HerdmanSell SJune 15, 2026June 15, 20260d1,899$25$47K10b5-1 planForm 4 ↗
Horn HowardSell SJune 1, 2026June 1, 20260d4,653$24$111K10b5-1 planForm 4 ↗
Fust Matthew KOther AMay 14, 2026May 18, 20264d14,058——derivativeForm 4 ↗
Fust Matthew KOther AMay 14, 2026May 18, 20264d7,751——Form 4 ↗
SULIMAN SHEHNAAZOther AMay 14, 2026May 18, 20264d14,058——10b5-1 planderivativeForm 4 ↗
SULIMAN SHEHNAAZSell SMay 18, 2026May 18, 20260d5,740$25$144K10b5-1 planForm 4 ↗
SULIMAN SHEHNAAZOther AMay 14, 2026May 18, 20264d7,751——10b5-1 planForm 4 ↗
Ray AmritOther AMay 14, 2026May 18, 20264d14,058——derivativeForm 4 ↗
Ray AmritOther AMay 14, 2026May 18, 20264d7,751——Form 4 ↗
Sanders Corazon (Corsee) D.Other AMay 14, 2026May 18, 20264d14,058——derivativeForm 4 ↗
Sanders Corazon (Corsee) D.Other AMay 14, 2026May 18, 20264d7,751——Form 4 ↗
NARACHI MICHAELOther AMay 14, 2026May 18, 20264d14,058——derivativeForm 4 ↗
NARACHI MICHAELOther AMay 14, 2026May 18, 20264d7,751——Form 4 ↗
WELCH DANIEL GOther AMay 14, 2026May 18, 20264d14,058——derivativeForm 4 ↗
WELCH DANIEL GOther AMay 14, 2026May 18, 20264d7,751——Form 4 ↗
Dunsire DeborahOther AMay 14, 2026May 18, 20264d14,058——derivativeForm 4 ↗
Dunsire DeborahOther AMay 14, 2026May 18, 20264d7,751——Form 4 ↗
Crombez EricSell SMay 5, 2026May 6, 20261d344$25$8,586Form 4 ↗
Horn HowardSell SMay 1, 2026May 4, 20263d4,683$25$117K10b5-1 planForm 4 ↗
Huizenga Theodore AlanOther AApril 22, 2026April 24, 20262d7,348——derivativeForm 4 ↗
Huizenga Theodore AlanOther AApril 22, 2026April 24, 20262d20,241——Form 4 ↗
KAKKIS EMIL DOther AApril 16, 2026April 20, 20264d132,693——derivativeForm 4 ↗
KAKKIS EMIL DOther AApril 16, 2026April 20, 20264d76,745——Form 4 ↗
Huang Dennis KarlOther AApril 16, 2026April 20, 20264d79,936——derivativeForm 4 ↗
Huang Dennis KarlOther AApril 16, 2026April 20, 20264d23,116——Form 4 ↗
Pinion John RichardOther AApril 16, 2026April 20, 20264d79,936——derivativeForm 4 ↗
Pinion John RichardOther AApril 16, 2026April 20, 20264d23,116——Form 4 ↗
Parschauer Karah HerdmanOther AApril 16, 2026April 20, 20264d49,960——derivativeForm 4 ↗
Parschauer Karah HerdmanOther AApril 16, 2026April 20, 20264d28,895——Form 4 ↗
Harris ErikOther AApril 16, 2026April 20, 20264d49,960——derivativeForm 4 ↗
Harris ErikOther AApril 16, 2026April 20, 20264d28,895——Form 4 ↗
Crombez EricOther AApril 16, 2026April 20, 20264d59,952——derivativeForm 4 ↗
Crombez EricOther AApril 16, 2026April 20, 20264d34,674——Form 4 ↗
Horn HowardOther AApril 16, 2026April 20, 20264d59,952——derivativeForm 4 ↗
Horn HowardOther AApril 16, 2026April 20, 20264d34,674——Form 4 ↗
Horn HowardSell SApril 1, 2026April 2, 20261d4,683$21$98K10b5-1 planForm 4 ↗
Parschauer Karah HerdmanSell SMarch 10, 2026March 10, 20260d3,508$23$80KForm 4 ↗
Parschauer Karah HerdmanSell SMarch 6, 2026March 10, 20264d6,018$21$129KForm 4 ↗
Pinion John RichardSell SMarch 2, 2026March 3, 20261d10,029$23$229KForm 4 ↗
Pinion John RichardOther AMarch 1, 2026March 3, 20262d11,137——Form 4 ↗
Harris ErikSell SMarch 2, 2026March 3, 20261d10,539$23$240KForm 4 ↗
Harris ErikOther AMarch 1, 2026March 3, 20262d11,643——Form 4 ↗
KAKKIS EMIL DSell SMarch 2, 2026March 3, 20261d54,404$23$1.2MForm 4 ↗
KAKKIS EMIL DOther AMarch 1, 2026March 3, 20262d71,177——Form 4 ↗
Parschauer Karah HerdmanSell SMarch 2, 2026March 3, 20261d8,135$23$185KForm 4 ↗
Parschauer Karah HerdmanOther AMarch 1, 2026March 3, 20262d11,137——Form 4 ↗
Huizenga Theodore AlanSell SMarch 2, 2026March 3, 20261d1,632$23$37KForm 4 ↗
Huizenga Theodore AlanSell FMarch 2, 2026March 3, 20261d148$23$3,462Form 4 ↗
Horn HowardSell SMarch 3, 2026March 3, 20260d1,635$22$37K10b5-1 planForm 4 ↗
Horn HowardSell SMarch 2, 2026March 3, 20261d3,119$23$70K10b5-1 planForm 4 ↗
Horn HowardSell SMarch 2, 2026March 3, 20261d5,290$23$121K10b5-1 planForm 4 ↗
Horn HowardOther AMarch 1, 2026March 3, 20262d6,143——10b5-1 planForm 4 ↗
Crombez EricSell SMarch 2, 2026March 3, 20261d7,029$23$160KForm 4 ↗
Crombez EricOther AMarch 1, 2026March 3, 20262d11,643——Form 4 ↗
Huang Dennis KarlSell FMarch 2, 2026March 3, 20261d999$23$23KForm 4 ↗
Huang Dennis KarlOther AMarch 1, 2026March 3, 20262d11,137——Form 4 ↗
Horn HowardSell SFebruary 2, 2026February 3, 20261d3,061$24$72K10b5-1 planForm 4 ↗
Horn HowardSell SJanuary 2, 2026January 5, 20263d3,150$23$72K10b5-1 planForm 4 ↗
Huizenga Theodore AlanSell SDecember 29, 2025December 30, 20251d85$34$2,922Form 4 ↗
Horn HowardSell SDecember 10, 2025December 11, 20251d3,081$36$112K10b5-1 planForm 4 ↗
Horn HowardSell SOctober 13, 2025October 14, 20251d7,942$32$250KForm 4 ↗

Congressional trades

FilerSideTrade dateDisclosedLagSharesPriceValueFlagsSourceShare
Gilbert Ray Cisneros, Jr.BuySeptember 29, 2026October 12, 202613d——$1,001–$15KHouse PTR ↗
Gilbert Ray Cisneros, Jr.BuyMarch 3, 2026April 7, 202635d——$1,001–$15KHouse PTR ↗
Gilbert Ray Cisneros, Jr.BuyFebruary 18, 2026March 9, 202619d——$1,001–$15KHouse PTR ↗

Tickers traded by the same people who traded RARE, by number of filers in common. It shows overlap in public filings and nothing else.

  • MCK McKesson Corporation Common Stock 2 filers in common
  • CRWD CrowdStrike Holdings, Inc. - Class A Common Stock 1 filer in common
  • NET Cloudflare, Inc. Class A Common Stock 1 filer in common
  • UBER Uber Technologies, Inc. Common Stock 1 filer in common
  • DDOG Datadog, Inc. - Class A Common Stock 1 filer in common
  • CVNA Carvana Co. Class A Common Stock 1 filer in common
  • ANET Arista Networks, Inc. Common Stock 1 filer in common
  • CRDO Credo Technology Group Holding Ltd - Ordinary Shares 1 filer in common

Guides for this page

Sources and method

Official sources behind this page
SourceFilingsRowsFirst filedNewest filedRead the originals
House Clerk, periodic transaction reports33March 9, 2026October 12, 2026House Clerk search
SEC EDGAR, Form 44168October 14, 2025October 19, 2026Form 4 list on EDGAR

Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.

Insider rows are Form 4 filings for this issuer from SEC EDGAR; congressional rows are periodic transaction reports parsed from the House Clerk and the Senate eFD. Values use the reported price for Form 4 and the disclosed range for Congress. See methodology and corrections.

Not investment advice. Disclosures are shown as filed and may lag the trade or be amended. No recommendation is made or implied.